3B61

emre multidrug transporter, apo crystal form

• Total interactions analyzed: 28
• Total true interactions: 6
• Strongest Interaction:
  • Chains: E-G
  • Int. Res.: 9
  • Norm. En. per Res.: -0.031
• Hub Node: A(2)

All Interactions

Chains	Hydro. Bond Ener. (kJ/mol)	Elec. Ener. (kJ/mol)	VDW. Ener. (kJ/mol)	Tot. Stab. Ener. (kJ/mol)	#int. res.	# Short cont.	#Hydr. int.	#VDW pairs	#salt bridges	#Pot. fav. elec. int	#Pot. unfav. elec. int
A-B	0.0	0.0	-0.6548	-0.6548	31	0	0	263	0	0	0
A-C	0.0	0.0	-0.2215	-0.2215	8	0	0	37	0	0	0
C-D	0.0	0.0	-0.7975	-0.7975	32	0	0	289	0	0	0
E-F	0.0	0.0	-0.7518	-0.7518	33	0	0	278	0	0	0
E-G	0.0	0.0	-0.2786	-0.2786	9	0	0	59	0	0	0
G-H	0.0	0.0	-0.7432	-0.7432	34	0	0	286	0	0	0

Interface residues

• A-B: ALA42A, ALA42B, CYS39A, CYS39B, GLY35A, GLY35B, GLY65A, GLY65B, ILE38A, ILE38B, ILE58A, ILE62A, ILE62B, ILE68A, ILE88A, LEU46B, LEU73A, LEU73B, LEU74B, MET92A, PHE78B, SER43B, SER72A, SER72B, SER75A, TRP45B, VAL34A, VAL66A, VAL66B, VAL69A, VAL69B
• A-C: ALA10A, ALA10C, ALA13A, ALA13C, ILE16A, ILE16C, LEU12A, LEU12C
• C-D: ALA42C, ALA42D, CYS39C, CYS39D, CYS95C, GLY35C, GLY35D, GLY65C, GLY65D, ILE38C, ILE38D, ILE62C, ILE62D, ILE68C, ILE88C, LEU46D, LEU70D, LEU73C, LEU73D, LEU74D, MET92C, SER43D, SER72C, SER72D, SER75C, TRP45D, TYR40D, VAL34C, VAL66C, VAL66D, VAL69C, VAL69D
• E-F: ALA42E, ALA42F, CYS39E, CYS39F, GLY35E, GLY35F, GLY65E, GLY65F, ILE38E, ILE38F, ILE58E, ILE62E, ILE62F, ILE68E, ILE88E, LEU46F, LEU70F, LEU73E, LEU73F, LEU74F, MET92E, PHE78F, SER43F, SER72E, SER72F, SER75E, TRP45F, TYR40F, VAL34E, VAL66E, VAL66F, VAL69E, VAL69F
• E-G: ALA10E, ALA10G, ALA13E, ALA13G, GLY9E, ILE16E, ILE16G, LEU12E, LEU12G
• G-H: ALA42G, ALA42H, ALA96G, CYS39G, CYS39H, CYS95G, GLY35G, GLY35H, GLY65G, GLY65H, GLY67H, ILE38G, ILE38H, ILE62G, ILE62H, ILE68G, ILE88G, LEU46H, LEU70H, LEU73G, LEU73H, LEU74G, LEU74H, MET92G, SER43H, SER72G, SER72H, SER75G, TRP45H, TYR40H, VAL34G, VAL66H, VAL69G, VAL69H